MITOCHONDRIAL REDOX IMAGING FOR CANCER DIAGNOSTIC AND THERAPEUTIC STUDIES.

Area of Science:

• Biomedical imaging
• Metabolic imaging
• Cancer research

Background:

• Mitochondrial redox states are crucial indicators of cellular energy metabolism and signaling in diseases like cancer.
• The established redox scanning method provides 3D high-resolution imaging of mitochondrial redox state based on NADH and Fp fluorescence.

Purpose of the Study:

• To review the principles, technical developments, and biomedical applications of mitochondrial redox imaging.
• To highlight advancements in quantitative analysis and high-speed 3D imaging for cancer research in small animal models.

Main Methods:

• Utilizes the fluorescence of reduced nicotinamide adenine dinucleotide (NADH) and oxidized flavoproteins (Fp) for redox state imaging.
• Incorporates recent calibration procedures for quantifying NADH and Fp concentrations and redox ratios.
• Employs a CCD detector-based redox imager for faster 3D image acquisition with improved resolution.

Main Results:

• Quantitative calibration allows for comparable redox imaging results across different metabolic states and instrumental settings.
• The CCD imager enables faster ex vivo and in vivo imaging of tissue mitochondrial redox status.
• Demonstrated applications in small animal cancer models, including metabolic imaging, metastasis prediction, precancerous tissue differentiation, and treatment response monitoring.

Conclusions:

• Mitochondrial redox imaging is a powerful tool for understanding tissue metabolism and its role in cancer.
• Technical advancements have enhanced the quantitative accuracy and speed of redox imaging.
• The method shows significant potential for cancer diagnostics, therapeutic studies, and monitoring in preclinical settings.